4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052334
Director bought 55,000 shares at $18.00 ($990,000)
- Director acquired 6,414,356 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
ORONSKY ARNOLD L · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-25 | Purchase : show line 1 in the form | +55,000 | $18.00 | $990,000 | 55,000 | I |
| 2020-09-29 | Conversion : show line 2 in the form | +1,620,101 | 1,675,101 | I | ||
| 2020-09-29 | Conversion : show line 3 in the form | +3,488,398 | 5,163,499 | I | ||
| 2020-09-29 | Conversion : show line 4 in the form | +1,040,654 | 6,204,153 | I | ||
| 2020-09-29 | Conversion : show line 5 in the form | +265,203 | 6,469,356 | I | ||
| Open-market purchases · 55,000 sh · avg $18.00 · $990,000 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-29 | Conversion : show line 6 in the form Series Seed Preferred Stock | −1,620,101 | 0 | I |
| 2020-09-29 | Conversion : show line 7 in the form Series A Preferred Stock | −3,488,398 | 0 | I |
| 2020-09-29 | Conversion : show line 8 in the form Series B Preferred Stock | −1,040,654 | 0 | I |
| 2020-09-29 | Conversion : show line 9 in the form Series C Preferred Stock | −265,203 | 0 | I |
Loading xslF345X03/doc4.xml…